Abi Vijenthira
About
In The Last Decade
Abi Vijenthira
34 papers receiving 842 citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 420
- Infectious Diseases 320
- Hematology 135
- Genetics 124
- Immunology 96
Countries citing papers authored by Abi Vijenthira
This map shows the geographic impact of Abi Vijenthira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abi Vijenthira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abi Vijenthira more than expected).
Fields of papers citing papers by Abi Vijenthira
This network shows the impact of papers produced by Abi Vijenthira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abi Vijenthira. The network helps show where Abi Vijenthira may publish in the future.
Co-authorship network of co-authors of Abi Vijenthira
This figure shows the co-authorship network connecting the top 25 collaborators of Abi Vijenthira. A scholar is included among the top collaborators of Abi Vijenthira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abi Vijenthira. Abi Vijenthira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 0 | |
| 8 | Antibody–drug conjugates: in search of partners of choice breakdown → | 128 |
| 9 | 15 | |
| 10 | 11 | |
| 11 | 5 | |
| 12 | 15 | |
| 13 | 17 | |
| 14 | Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients breakdown → | 330 |
| 15 | 21 | |
| 16 | 11 | |
| 17 | 1 | |
| 18 | 1 | |
| 19 | 14 | |
| 20 | 37 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.